Expression and prognostic significance of hsa-miR-142-3p in acute leukemias

Neoplasma

Volumn 60, Issue 4, 2013, Pages 432-438

  Dahlhaus, M ^a   Roolf, C ^a   Ruck, S ^a   Lange, S ^a   Freund, M ^a   Junghanss, C ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Leukemia; microRNA; Prognostic factor

Indexed keywords

CD34 ANTIGEN; MICRORNA; MICRORNA 142 3P; UNCLASSIFIED DRUG; MIRN142 MICRORNA, HUMAN;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MIDDLE AGED; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; YOUNG ADULT; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; GENETICS; MORTALITY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

MLCS; MLOWN;

EID: 84880438477     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_056     Document Type: Article

References (21)

1. YENDAMURI S, CALIN GA. The role of microRNA in human leukemia: a review. Leukemia. 2009; 23: 1257-63. http://dx.doi.org/10.1038/leu.2008.382
2. CALIN GA, CIMMINO A, FABBRI M, FERRACIN M, WOJCIK SE et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008; 105: 5166-71. http://dx.doi.org/10.1073/pnas.0800121105
3. MI S, LU J, SUN M, LI Z, ZHANG H et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A. 2007; 104: 19971-6. http://dx.doi.org/10.1073/pnas.0709313104
4. DEBERNARDI S, SKOULAKIS S, MOLLOY G, CHAPLIN T, DIXON-MCIVER A, et al. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia. 2007; 21: 912-6.
5. GARZON R, VOLINIA S, LIU CG, FERNANDEZ-CYMERING C, PALUMBO T et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008; 111: 3183-9. http://dx.doi.org/10.1182/blood-2007-07-098749
6. GAUWERKY CE, HUEBNER K, ISOBE M, NOWELL PC, CROCE CM. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc Natl Acad Sci U S A. 1989; 86: 8867-71. http://dx.doi.org/10.1073/pnas.86.22.8867
7. LANDGRAF P, RUSU M, SHERIDAN R, SEWER A, IOVINO N et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129: 1401-14. http://dx.doi.org/10.1016/j.cell.2007.04.040
8. NISHIYAMA T, KANEDA R, ONO T, TOHYAMA S, HASHIMOTO H et al. miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish. Biochem Biophys Res Commun. 2012 Sep 7;425(4):755-61. http://dx.doi.org/10.1016/j.bbrc.2012.07.148
9. YUAN W, SUN W, YANG S, DU J, ZHAI CL et al. Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors. Leukemia. 2008; 22: 1067-71. http://dx.doi.org/10.1038/sj.leu.2405001
10. GUENTHER MG, JENNER RG, CHEVALIER B, NAKAMURA T, CROCE CM et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A. 2005; 102: 8603-8. http://dx.doi.org/10.1073/pnas.0503072102
11. BRACHT K, KIEFER T, DOLKEN G, BEDNARSKI PJ. Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status. J Cancer Res Clin Oncol. 2007; 133: 957-67. http://dx.doi.org/10.1007/s00432-007-0241-x
12. PFAFFL MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: e45. http://dx.doi.org/10.1093/nar/29.9.e45
13. PFAFFL MW, HORGAN GW, DEMPFLE L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in realtime PCR. Nucleic Acids Res. 2002; 30:e36. http://dx.doi.org/10.1093/nar/30.9.e36
14. GRIMWADE D, WALKER H, OLIVER F, WHEATLEY K, HARRISON C et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. TheMedical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998; 92: 2322-33.
15. FELLI N, PEDINI F, ROMANIA P, BIFFONI M, MORSILLI O et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica. 2009; 94: 479-86. http://dx.doi.org/10.3324/haematol.2008.002345
16. NEILSON JR, ZHENG GXY, BURGE CB, SHARP PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 2007; 21: 578-89. http://dx.doi.org/10.1101/gad.1522907
17. SHARMA VM, DRAHEIM KM, KELLIHER MA. The Notch1/ c-Myc pathway in T cell leukemia. Cell Cycle. 2007; 6: 927-30. http://dx.doi.org/10.4161/cc.6.8.4134
18. SCHOTTE D, CHAU JC, SYLVESTER G, LIU G, CHEN C et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia. 2008; 23: 313-22. http://dx.doi.org/10.1038/leu.2008.286
19. KASASHIMA K, NAKAMURA Y, KOZU T. Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun. 2004; 322:403-10. http://dx.doi.org/10.1016/j.bbrc.2004.07.130
20. MERKEROVA M, BELICKOVA M, BRUCHOVA H. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol. 2008; 81: 304-10. http://dx.doi.org/10.1111/j.1600-0609.2008.01111.x
21. GARZON R, GAROFALO M, MARTELLI MP, BRIESEWITZ R, WANG L et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A. 2008; 105: 3945-50. http://dx.doi.org/10.1073/pnas.0800135105